Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
about
Refractory asthma: mechanisms, targets, and therapy.Differential induction of total IgE by two Salmonella enterica serotypes.Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in miceDose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor.The relationship between autoimmunity and specific immunotherapy for allergic diseases.A tale of two cytokines: IL-17 and IL-22 in asthma and infection.Immunobiology of the critical asthma syndrome.Allergen immunotherapy, routes of administration and cytokine networks: an update.Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis.Asthma biomarkers in the age of biologics.
P2860
Q34788832-8A8C4E6D-9308-47AB-9981-49F1775C8272Q35646842-A404C11E-92F6-4D75-96D0-43ECF0D9F997Q36492808-B8647C40-F7A6-4F29-9E67-D92BE5243269Q37128293-F78B2A18-0844-4C9F-87C0-73D37DE756AAQ37320206-BB8E7DA8-D203-4909-9743-6327B85FE6E1Q38170180-FD88B107-FFBA-4BF0-BF98-EAD418D109D1Q38176551-8F25E0AE-1714-4321-9231-5F0A65C29700Q38245926-AA816F26-AE60-4703-8E88-2C54CD0A8D86Q38584529-ABB0786C-99CD-48B6-8395-21E406AC98E1Q47141013-374D9F57-B78F-47C4-873B-9FAEB69A9CBEQ47169950-7DE742A7-C09D-444E-BFD8-7F602D56C8CF
P2860
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
@en
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.
@nl
type
label
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
@en
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.
@nl
prefLabel
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
@en
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.
@nl
P2093
P2860
P1476
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders
@en
P2093
John F Alcorn
Keven M Robinson
Michelle L Manni
Partha S Biswas
P2860
P2888
P304
P356
10.1007/S11882-013-0361-0
P577
2013-12-01T00:00:00Z